A Market Review of DNA-encoded Libraries Technology in Drug Discovery
(Last updated: October 05, 2022)
The interest of pharma organizations in DNA-encoded chemical libraries (DEL) technology has been growing over the years, with numerous pharma organizations now having their internal screening programs using DELs or outsourcing capabilities from specialized DEL providers.
This report provides a bird's view of the DEL market, including a summary of DEL technology benefits and limitations, key players, major research deals, and several examples of successful hit discovery programs using DELs.
Topics: Tools & Methods